Disclosures for "Expected Centiloid Values for Patients with Positive Visual Reads of Amyloid PET Scans "
-
Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities.
-
Miss Hyland has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
-
Mr. Scott has nothing to disclose.
-
Dr. feaster has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. feaster has stock in Acumen Pharmaceuticals.
-
Dr. Sethuraman has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Sethuraman has stock in Acumen Pharmaceuticals.